Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal. [electronic resource]
Producer: 19920403Description: 179-83 p. digitalISSN:- 0001-5598
- Adenoma -- drug therapy
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bromocriptine -- administration & dosage
- Growth Hormone -- metabolism
- Humans
- Magnetic Resonance Imaging
- Male
- Octreotide -- administration & dosage
- Pituitary Neoplasms -- drug therapy
- Prolactin -- metabolism
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.